Crypto experts predict Bitcoin price spike to $115,000 in 2024 after halving event By Investing.com
[ad_1] Amidst anticipation surrounding BTC’s upcoming halving event in 2024, cryptocurrency experts project a potential surge in price, with historical data suggesting significant growth and...
Ethereum price whipsaws on headlines concerning SEC’s regulatory probe By Investing.com
[ad_1] © Reuters price has made fresh gains today, showing resilience amidst a volatile crypto market. Gains are sustained despite the fact that the Securities...
Solana price pullback could deepen amid crypto regulatory concerns By Investing.com
[ad_1] Amid a broader downturn in the cryptocurrency market, with and facing declines, price has also seen a strong pullback. The token saw its value...
Macquarie maintains Hilton neutral rating despite positives By Investing.com
[ad_1] © Reuters. Macquarie maintains Hilton (HLT) neutral rating despite positives Analysts at Macquarie Equity Research view Hilton’s (HLT) stock favorably, describing it as the...
IGC Pharma reports promising Alzheimer’s treatment results By Investing.com
[ad_1] © Reuters. POTOMAC, Md. – IGC Pharma Inc. (NYSE American: IGC) has shared interim results from its Phase 2 clinical trial of IGC-AD1, which...
BitMEX flash crash: What happened to Bitcoin price on this exchange? By Investing.com
[ad_1] © Reuters. (BTC) price experienced a brief but severe crash on the cryptocurrency exchange BitMEX late Monday, plummeting to as low as $8,900 while...
Bitcoin mining stocks: JPMorgan revisits coverage amid crypto selloff By Investing.com
[ad_1] © Reuters. This week, mining stocks experienced losses amidst a broader weakening in Bitcoin prices. Despite a multi-day correction phase that appears to be...
Chemours secures $60 million in DOE hydrogen grants By Investing.com
[ad_1] © Reuters. WILMINGTON, Del. – The Chemours Company (NYSE:), a global leader in chemical solutions, announced it has been awarded $60 million in grants...
Acelyrin reports positive early trial results for TED therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Acelyrin Inc. (NASDAQ:SLRN), a biopharmaceutical company specializing in immunology treatments, has announced promising early results from its Phase 1/2...
Supermicro sets public offering price at $875 a share By Investing.com
[ad_1] © Reuters. SAN JOSE, Calif. – Super Micro Computer, Inc. (NASDAQ: NASDAQ:), known as Supermicro, has announced the pricing of its public offering of...